BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20144401)

  • 21. Insulin-loaded alginic acid nanoparticles for sublingual delivery.
    Patil NH; Devarajan PV
    Drug Deliv; 2016; 23(2):429-36. PubMed ID: 24901208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The physiological rationale for oral insulin administration.
    Arbit E
    Diabetes Technol Ther; 2004 Aug; 6(4):510-7. PubMed ID: 15321008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary insulin administration using the AERx insulin diabetes system.
    Thipphawong J; Otulana B; Clauson P; Okikawa J; Farr SJ
    Diabetes Technol Ther; 2002; 4(4):499-504. PubMed ID: 12396744
    [No Abstract]   [Full Text] [Related]  

  • 25. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung.
    Patton JS
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of oral sulfonylurea agents on hepatic glucose uptake.
    Kawamori R; Morishima T; Kubota M; Matsuhisa M; Ikeda M; Kamada T
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S109-13. PubMed ID: 8529503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid hyperglycemia.
    Khurana A; Vinayek N
    J Hosp Med; 2007 Jul; 2(4):285; author reply 285-6. PubMed ID: 17705218
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biotechnological and administration innovations in insulin therapy].
    Verge D
    Med Sci (Paris); 2004 Nov; 20(11):986-98. PubMed ID: 15525494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.
    Edgerton DS; Scott M; Farmer B; Williams PE; Madsen P; Kjeldsen T; Brand CL; Fledelius C; Nishimura E; Cherrington AD
    JCI Insight; 2019 Feb; 5(7):. PubMed ID: 30830873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Mutlu-Agardan NB; Han S
    Pharm Dev Technol; 2021 Feb; 26(2):157-166. PubMed ID: 33183103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release profile of insulin from pH-sensitive hydrogel and its hypoglycemic effect by oral administration.
    Shi Y; Wang X; Deng X; Tian R; Zhang Y; Shang Q; Chen N
    J Biomater Sci Polym Ed; 2016; 27(1):86-96. PubMed ID: 26498982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.
    Xia CQ; Wang J; Shen WC
    J Pharmacol Exp Ther; 2000 Nov; 295(2):594-600. PubMed ID: 11046093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
    Jaafar MHM; Hamid KA
    Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotinylated liposomes as potential carriers for the oral delivery of insulin.
    Zhang X; Qi J; Lu Y; He W; Li X; Wu W
    Nanomedicine; 2014 Jan; 10(1):167-76. PubMed ID: 23891617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocytes as oral delivery systems for human insulin.
    Al-Achi A; Greenwood R
    Drug Dev Ind Pharm; 1998 Jan; 24(1):67-72. PubMed ID: 15605599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
    Akram M; Naqvi SB; Khan A
    Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inpatient hyperglycemia: slide through the scale but cover the bases first.
    Asudani D; Calles-Escandon J
    J Hosp Med; 2007; 2 Suppl 1():23-32. PubMed ID: 17311238
    [No Abstract]   [Full Text] [Related]  

  • 40. [The enhancing effect of tomato lectin modified liposomes of insulin on oral absorption in mice].
    Zhang N; Ping QN; Xu WF
    Yao Xue Xue Bao; 2004 May; 39(5):380-4. PubMed ID: 15338884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.